文献速递颈动脉与弓上血管

近期心肌梗死患者颈动脉血运重建方式特异性结局

Modality-specific outcomes of patients undergoing carotid revascularization in the setting of recent myocardial infarction.
PubMed 文献 · J Vasc Surg · 2023-09-22

基于血管质量倡议(2016-2022)数据,比较近期心肌梗死(<6个月)患者接受颈动脉内膜剥脱术(CEA)、经股动脉颈动脉支架置入术(TFCAS)或经颈动脉血运重建术(TCAR)的院内结局。调整混杂后,TFCAS较CEA增加卒中/死亡和卒中/死亡/心梗风险,TCAR与CEA结局相似。

要点

  • 近期心梗患者中,TFCAS较CEA增加卒中/死亡风险(aOR 2.69)和卒中/死亡/心梗风险(aOR 1.67)。
  • TCAR与CEA相比,卒中/死亡/心梗结局相似。
  • TFCAS和TCAR均较CEA增加术后低血压风险、降低术后高血压风险。

核心结论

  • 尽管近期心梗是CEA的高危标准且为TFCAS的批准适应证,本研究表明在该人群中CEA更安全,卒中/死亡和卒中/死亡/心梗风险低于TFCAS。
  • TCAR在近期心梗患者中与CEA相比卒中/死亡/心梗结局相似。
  • 需要进一步的前瞻性研究来证实本研究发现。

研究设计与样本

  • 数据来自血管质量倡议(2016-2022),纳入美国和加拿大因颈动脉狭窄且近期心梗(<6个月)接受CEA、TFCAS或TCAR的患者。
  • 比较TFCAS vs CEA和TCAR vs CEA的院内结局,二次分析比较TCAR vs TFCAS。
  • 使用逻辑回归模型调整潜在混杂因素后比较三种手术的结局。

主要发现

  • 最终队列包括CEA 1217例(54.2%)、TFCAS 445例(19.8%)、TCAR 584例(26.0%)。
  • 单因素分析中,CEA与较低的同侧卒中(P = .079)、死亡(P = .002)和30天死亡率(P = .007)相关。
  • 调整混杂后,TFCAS较CEA增加卒中/死亡风险(aOR 2.69;95%CI 1.36-5.35;P = .005)和卒中/死亡/心梗风险(aOR 1.67;95%CI 1.07-2.60;P = .025)。
  • TCAR与CEA相比结局相似。
  • TFCAS和TCAR均较CEA增加术后低血压风险(aOR 1.62;95%CI 1.18-2.23;P = .003和aOR 1.74;95%CI 1.31-2.32;P ≤ .001)并降低术后高血压风险(aOR 0.59;95%CI 0.36-0.95;P = .029和aOR 0.50;95%CI 0.36-0.71;P ≤ .001)。

临床怎么用

  • 作者认为,在近期心梗患者中CEA较TFCAS更安全,卒中/死亡和卒中/死亡/心梗风险更低。
  • 作者指出TCAR在近期心梗患者中与CEA相比卒中/死亡/心梗结局相似。
  • 作者建议需要进一步的前瞻性研究来证实上述发现。

局限性

  • 需要进一步的前瞻性研究来证实本研究发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recent myocardial infarction (MI) represents a real challenge in patients requiring any vascular procedure. There is currently a lack of data on the effect of preoperative MI on the outcomes of carotid revascularization methodology (carotid enterectomy [CEA], transfemoral carotid artery stenting [TFCAS], or transcarotid artery revascularization [TCAR]). This study looks to identify modality-specific outcomes for patients with recent MI undergoing carotid revascularization. METHODS: Data was collected from the Vascular Quality Initiative (2016-2022) for patients with carotid stenosis in the United States and Canada with recent MI (<6 months) undergoing CEA, TFCAS, or TCAR. In-hospital outcomes after TFCAS vs CEA and TCAR vs CEA were compared. TCAR vs TFCAS were compared in a secondary analysis. We used logistic regression models to compare the outcomes of these three procedures in patients with recent MI, adjusting for potential confounders. Primary outcomes included 30-day in-hospital rates of stroke, death, and MI. Secondary outcomes included stroke/death, stroke/death/MI, postoperative hypertension, postoperative hypotension, prolonged length of stay (>2 days), and 30-day mortality. RESULTS: The final cohort included 1217 CEA (54.2%), 445 TFCAS (19.8%), and 584 TCAR (26.0%) cases. Patients undergoing CEA were more likely to have prior coronary artery bypass graft/percutaneous coronary intervention and to use anticoagulant. Patients undergoing TFCAS were more likely to be symptomatic, have prior congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, and undergo urgent operations. Patients undergoing TCAR were more likely to have higher rates of American Society of Anesthesiologists class IV to V, P2Y12 inhibitor, and protamine use. In the univariate analysis, CEA was associated with a lower rate of ipsilateral stroke (P = .079), death (P = .002), and 30-day mortality (P = .007). After adjusting for confounders, TFCAS was associated with increased risk of stroke/death (adjusted odds ratio [aOR], 2.69; 95% confidence interval [CI], 1.36-5.35; P = .005) and stroke/death/MI (aOR, 1.67; 95% CI, 1.07-2.60; P = .025) compared with CEA. However, TCAR had similar outcomes compared with CEA. Both TFCAS and TCAR were associated with increased risk of postoperative hypotension (aOR, 1.62; 95% CI, 1.18-2.23; P = .003 and aOR, 1.74; 95% CI, 1.31-2.32; P ≤ .001, respectively) and decreased risk of postoperative hypertension (aOR, 0.59; 95% CI, 0.36-0.95; P = .029 and aOR, 0.50; 95% CI, 0.36-0.71; P ≤ .001, respectively) compared with CEA. CONCLUSIONS: Although recent MI has been established as a high-risk criterion for CEA and an approved indication for TFCAS, this study showed that CEA is safer in this population with lower risk of stroke/death and stroke/death/MI compared with TFCAS. TCAR had similar stroke/death/MI outcomes in comparison to CEA in patients with recent MI. Further prospective studies are needed to confirm our findings.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Straus S, Moghaddam M, Zarrintan S, et al. Modality-specific outcomes of patients undergoing carotid revascularization in the setting of recent myocardial infarction. J Vasc Surg. 2023. PMID: 37742732. doi:10.1016/j.jvs.2023.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。